Detalhe da pesquisa
1.
Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
Catheter Cardiovasc Interv
; 89(6): 984-991, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27545721
2.
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.
Eur Heart J
; 36(47): 3332-42, 2015 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26330419
3.
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
N Engl J Med
; 362(18): 1663-74, 2010 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-20445180
4.
Low stent thrombosis risk with the XIENCE V® Everolimus-Eluting Coronary Stent: evidence from randomized and single-arm clinical trials.
J Interv Cardiol
; 24(4): 326-41, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21443551
5.
Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials.
Eur Heart J
; 31(9): 1071-8, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-20118171
6.
Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.
PLoS One
; 16(3): e0248889, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33755690
7.
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry.
Catheter Cardiovasc Interv
; 75(2): 179-86, 2010 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19877267
8.
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial.
Catheter Cardiovasc Interv
; 76(5): 644-51, 2010 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20506356
9.
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Catheter Cardiovasc Interv
; 74(5): 719-27, 2009 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19530147
10.
Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies.
Inflamm Bowel Dis
; 25(12): 1906-1918, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31173627
11.
Detection of adventitious agents using next-generation sequencing.
PDA J Pharm Sci Technol
; 68(6): 651-60, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25475640
12.
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
JACC Cardiovasc Interv
; 6(9): 914-22, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24050859
13.
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents.
EuroIntervention
; 7(9): 1030-42, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22207228
14.
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Circ Cardiovasc Interv
; 5(2): 150-6, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22438430
15.
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.
EuroIntervention
; 8(1): 87-93, 2012 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22580252
16.
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
EuroIntervention
; 7(3): 307-13, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21729832